✦ LIBER ✦

Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis

✍ Scribed by A. A. Higazi; M. El-Haj; A. Melhem; A. Horani; O. Pappo; C. E. Alvarez; N. Muhanna; S. L. Friedman; R. Safadi

Book ID: 108699791
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 414 KB
Volume: 152
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.2008.03606.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Studies on hepatic fibrogenesis (XXI) ch

Studies on hepatic fibrogenesis (XXI) changes in hepatic hyaluronidase activity in chronic hepatic damage

✍ Koizumi, T. ;Nakamura, N. ;Iwahori, N. ;Furukawa, Y. ;Abe, H. 📂 Article 📅 1969 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

Stueies on hepatic fibrogenesis (xxvi) a

Stueies on hepatic fibrogenesis (xxvi) activities of acid mucopolysaccharide sulfotransferases in chronic hepatic injury

✍ Koizumi, T. ;Suematsu, T. ;Nakamura, N. ;Kawasaki, A. ;Furukawa, Y. ;Hiramatsu, 📂 Article 📅 1970 🏛 Springer-Verlag 🌐 English ⚖ 82 KB

Pharmacodynamic and Systemic Fibrinolyti

Pharmacodynamic and Systemic Fibrinolytic Effects of Plasminogen Activators in Man

✍ S. A. CEDERHOLM-WILLIAMS 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

Effects of malotilate treatment on the s

Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis

✍ Takase, Shujiro ;Takada, Akira ;Yasuhara, Minoru ;Sato, Hiroyuki ;Matsuda, Yoshi 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 592 KB

Studies on hepatic fibrogenesis (XVII) c

Studies on hepatic fibrogenesis (XVII) change in n-acetyl-β-glucosaminidase activity in hepatic damage

✍ Koizumi, T. ;Suematsu, T. ;Iwahori, N. ;Abe, H. 📂 Article 📅 1968 🏛 Springer-Verlag 🌐 English ⚖ 65 KB

Effect of oral defibrotide on tissue-pla

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance

✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done